Lighting up tumors with receptor-specific optical molecular probes

Technology in Cancer Research and Treatment

Volumn 3, Issue 4, 2004, Pages 393-409

  Achilefu, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bombesin; Carbocyanine dyes; Cell surface receptors; Contrast agents; Epidermal growth factor; Folate; Molecular probes; Neurotensin; Optical imaging; Somatostatin

Indexed keywords

CONTRAST MEDIUM;

CARCINOGENESIS; DIAGNOSTIC IMAGING; GENE EXPRESSION; LOW ENERGY RADIATION; MOLECULAR PROBE; NEAR INFRARED SPECTROSCOPY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; TUMOR DIAGNOSIS;

EID: 4143061376     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460400300410     Document Type: Review

References (207)

1. Shah, N., Cerussi, A., Eker, C., Espinoza, J., Butler, J., et al. Noninvasive Functional Optical Spectroscopy of Human Breast Tissue. Proc. Natl. Acad. Sci. USA 98, 4420-4425 (2001).
2. Hawrysz, D. J. and Sevick-Muraca, E. M. Developments Toward Diagnostic Breast Cancer Imaging Using Near-infrared Optical Measurements and Fluorescent Contrast Agents. Neoplasia 2, 388-417 (2000).
3. Ntziachristos, V., Tung, C. H., Bremer, C. and Weissleder, R. Fluorescence Molecular Tomography Resolves Protease Activity In Vivo. Nat Med 8, 757-760 (2002).
4. Hebden, J. C., Veenstra, H., Dehghani, H., Hillman, E. M. C., Schweiger, M., et al. Three-dimensional Time-resolved Optical Tomography of a Conical Breast Phantom. Appl. Optics 40, 3278-3287 (2001).
5. Culver, J. P., Ntziachristos, V., Holboke, M. J. and Yodh, A. G. Optimization of Optode Arrangements for Diffuse Optical Tomography: A Singular-value Analysis. Opt. Lett. 26, 701-703 (2001).
6. Hyde, D. E., Farrell, T. J., Patterson, M. S. and Wilson, B. C. A Diffusion Theory Model of Spatially Resolved Fluorescence From Depth-dependent Fluorophore Concentrations. Phys. Med. Biol. 46, 369-383 (2001).
7. Pogue, B. W., Geimer, S., McBride, T. O., Jiang, S. D., Osterberg, U. L., et al. Three-dimensional Simulation of Near-infrared Diffusion in Tissue: Boundary Condition and Geometry Analysis for Finite-element Image Reconstruction. Appl. Optics 40, 588-600 (2001).
8. McBride, T. O., Pogue, B. W., Gerety, E. D., Poplack, S. B., Osterberg, U. L., et al. Spectroscopic Diffuse Optical Tomography for the Quantitative Assessment of Hemoglobin Concentration and Oxygen Saturation in Breast Tissue. Appl. Optics 38, 5480-5490 (1999).
9. Schotland, J. C. Continuous-wave Diffusion Imaging. J. Opt. Soc. Am. A-Opt. Image Sci. Vis. 14, 275-279 (1997).
10. Lee, J. and Sevick-Muraca, E. Fluorescence-enhanced Absorption Imaging Using Frequency-domain Photon Migration: Tolerance to Measurement Error. J. Biomed. Opt. 6, 58-67 (2001).
11. Cheong, W. F., vanHouten, J. P., Kermit, E. L., Machold, T. R., Stevenson, D. K., et al. Pilot Comparison of Light-based Optical Tomography Versus Ultrasound for Real-time Imaging of Neonatal Intraventricular Hemorrhage. Pediatr. Res. 39, 1189-1189 (1996).
12. Rhine, W. D., Benaron, D. A., Darceuil, H. E., deCrespigny, A., Cheong, W. F., et al. Simultaneous Time of-flight Adjusted (TOFA) Near-infrared Spectroscopy and Magnetic Resonance Imaging of Immature Rabbit Hypoxic-ischemic Encephalopathy (HIE) Pediatr. Res. 39, 2264-2264 (1996).
13. Wagnieres, G. A., Star, W. M. and Wilson, B. C. In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications, Photochem. Photobiol. 68, 603-632 (1998).
14. Ntziachristos, V., Yodh, A. G., Schnall, M. and Chance, B. Concurrent MR1 and Diffuse Optical Tomography of Breast After Indocyanine Green Enhancement. Proc. Natl. Acad. Sci. USA 97, 2767-2772 (2000).
15. Cubeddu, R., Pifferi, A., Taroni, P., Torricelli, A., Valentini, G., et al. Fluorescence Imaging During Photodynamic Therapy of Experimental Tumors in Mice Sensitized with Disulfonated Aluminum Phthalocyanine. Photochem. Photobiol. 72, 690-695 (2000).
16. Cerussi, A. E., Jakubowski, D., Shah, N., Bevilacqua, F., Lanning, R., et al. Spectroscopy Enhances the Information Content of Optical Mammography. J. Biomed. Opt. 7, 60-71 (2002).
17. Villringer, A. and Chance, B. Non-invasive Optical Spectroscopy and Imaging of Human Brain Function. Trends Neurosci. 20, 435-442 (1997).
18. Tromberg, B. J., Shah, N., Lanning, R., Cerussi, A., Espinoza, J., et al. Non-invasive In Vivo Characterization of Breast Tumors Using Photon Migration Spectroscopy. Neoplasia 2, 26-40 (2000).
19. Young, A. R. Chromophores in Human Skin. Phys. Med. Biol. 42, 789-802 (1997).
20. Brancaleon, L., Durkin, A. J., Tu, J. H., Menaker, G., Fallon, J. D., et al. in Vivo Fluorescence Spectroscopy of Nonmelanoma Skin Cancer. Photochem. Photobiol. 73, 178-183 (2001).
21. Contag, C. H. and Bachmann, M. H. Advances In Vivo Bioluminescence Imaging of Gene Expression. Annu. Rev. Biomed Eng. 4, 235-260 (2002).
22. Soling, A. and Rainov, N. G. Bioluminescence Imaging in Vivo - Application to Cancer Research. Expert Opinion on Biological Therapy 3, 1163-1172 (2003).
23. Zimmer, M. Green Fluorescent Protein (GFP): Applications, Structure, and Related Photophysical Behavior. Chem. Rev. 102, 759-781 (2002).
24. Yu, Y. A., Timiryasova, T., Zhang, Q., Beltz, R. and Szalay, A. A. Optical Imaging: Bacteria, Viruses, and Mammalian Cells Encoding Light-emitting Proteins Reveal the Locations of Primary Tumors and Metastases in Animals. Anal. Bioanal. Chem. 377, 964-972 (2003).
25. Hoffman, R. M. Green Fluorescent Protein Imaging of Tumour Growth, Metastasis, and Angiogenesis in Mouse Models. Lancet Oncology 3, 546-556 (2002).
26. Hoffman, R. M. Green Fluorescent Protein Imaging of Tumor Cells in Mice. Lab Anim. 31, 34-41 (2002).
27. Bremer, C., Ntziachristos, V. and Weissleder, R. Optical-based Molecular Imaging: Contrast Agents and Potential Medical Applications. Eur. Radiol 13, 231-243 (2003).
28. Bogdanov, A. A., Lin, C. P., Simonova, M., Matuszewski, L. and Weissleder, R. Cellular Activation of the Self-quenched Fluorescent Reporter Probe in Tumor Microenvironment. Neoplasia 4, 228-236 (2002).
29. Funovics, M., Weissleder, R. and Tung, C. H. Protease Sensors for Bioimaging. Anal. Bioanal. Chem. 377, 956-963 (2003).
30. Mahmood, U. and Weissleder, R. Near-infrared Optical Imaging of Proteases in Cancer. Mol. Cancer Ther. 2, 489-496 (2003).
31. Weissleder, R. Scaling Down Imaging: Molecular Mapping of Cancer in Mice. Nat. Rev. Cancer 2, 11-18 (2002).
32. Brigger, I., Dubernet, C. and Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis. Adv. Drug Deliv. Rev. 54, 631-651 (2002).
33. Sahoo, S. K. and Labhasetwar, V. Nanotech Approaches to Delivery and Imaging Drug. Drug Discov. Today 8, 1112-1120 (2003).
34. West, J. L. and Halas, N. J. Engineered Nanomaterials for Biophotonics Applications: Improving Sensing, Imaging, and Therapeutics. Annu. Rev. Biomed. Eng. 5, 285-292 (2003).
35. Chan, W. C. W., Maxwell, D. J., Gao, X. H., Bailey, R. E., Han, M. Y., et al. Luminescent Quantum Dots for Multiplexed Biological Detection and Imaging. Curr. Opin. Biotechnol. 13, 40-46 (2002).
36. Gao, X. H. and Nie, S. M. Molecular Profiling of Single Cells and Tissue Specimens with Quantum Dots. Trends Biotechnol. 21, 371-373 (2003).
37. Benaron, D. A. The Future of Cancer Imaging. Cancer Metastasis Rev. 21, 45-78 (2002).
38. Frangioni, J. V. In Vivo Near-infrared Fluorescence Imaging. Curr. Opin. Chem. Biol. 7, 626-634 (2003).
39. Sevick-Muraca, E. M., Houston, J. P. and Gurfinkel, M. Fluorescence-enhanced, Near Infrared Diagnostic Imaging with Contrast Agents. Curr. Opin. Chem. Biol. 6, 642-650 (2002).
40. Weissleder, R. and Mahmood, U. Molecular Imaging. Radiology 219, 316-333 (2001).
41. Granberg, D., Sundin, A., Janson, E. T., Oberg, K., Skogseid, B., et al. Octreoscan in Patients with Bronchial Carcinoid Tumours. Clin. Endocrinol. 59, 793-799 (2003).
42. Arsene, S., Giraudeau, B., Le Lez, M. L., Pisella, P. J., Pourcelot, L., et al. Follow Up by Colour Doppler Imaging of 102 Patients with Retinal Vein Occlusion Over 1 Year. Br. J. Ophthalmol. 86, 1243-1247 (2002).
43. Kaiser, R. S., Berger, J. W., Williams, G. A., Tolentino, M. J., Maguire, A. M., et al. Variability in Fluorescein Angiography Interpretation for Photodynamic Therapy in Age-related Macular Degeneration. Retin.-J. Retin. Vitr. Dis. 22, 683-690 (2002).
44. Pflugfelder, S. C., Solomon, A. and Stern, M. E. The Diagnosis and Management of Dry eye - A Twenty-five Year Review. Cornea 19, 644-649 (2000).
45. Raabe, A., Beck, J., Gerlach, R., Zimmermann, M. and Seifert, V. Near-infrared Indocyanine Green Video Angiography: A New Method for Intraoperative Assessment of Vascular Flow. Neurosurgery 52, 132-139 (2003).
46. Shaikh, S., Ruby, A. J. and Williams, G. A. Photodynamic Therapy using Verteporfin for Choroidal Neovascularization in Angioid Streaks. Am. J. Ophthalmol. 135, 1-6 (2003).
47. Tsilou, E., Csaky, K., Rubin, B. I., Gahl, W. and Kaiser-Kupfer, M. Retinal Visualization in an Eye with Corneal Crystals using Indocyanine Green Videoangiography. Am. J. Ophthalmol. 134, 123-125 (2002).
48. Achilefu, S., Dorshow, R. B., Bugaj, J. E. and Rajagopalan, R. Novel Receptor-targeted Fluorescent Contrast Agents for In Vivo Tumor Imaging. Invest. Radiol. 35, 479-485 (2000).
49. Gurfinkel, M., Thompson, A. B., Ralston, W., Troy, T. L., Moore, A. L., et al. Pharmacokinetics of ICG and HPPH-car for the Detection of Normal and Tumor Tissue using Fluorescence, Near-infrared Reflectance Imaging: A Case Study. Photochem. Photobiol. 72, 94-102 (2000).
50. Intes, X., Ripoll, J., Chen, Y., Nioka, S., Yodh, A. G., et al. In Vivo Continuous-wave Optical Breast Imaging Enhanced with Indocyanine Green. Med. Phys. 30, 1039-1047 (2003).
51. Malicka, J., Gryczynski, I., Geddes, C. D. and Lakowicz, J. R. Metal-enhanced Emission from Indocyanine Green: A New Approach to In Vivo Imaging. J. Biomed. Opt. 8, 472-478 (2003).
52. Cuccia, D. J., Bevilacqua, F., Durkin, A. J., Merritt, S., Tromberg, B. J., et al. In Vivo Quantification of Optical Contrast Agent Dynamics in Rat Tumors by Use of Diffuse Optical Spectroscopy with Magnetic Resonance Imaging Coregistration. Appl. Optics 42, 2940-2950 (2003).
53. Mujumdar, R. B., Ernst, L. A., Mujumdar, S. R., Lewis, C. J. and Waggoner, A. S. Cyanine Dye Labeling Reagents - Sulfoindocyanine Succinimidyl Esters. Bioconjugate Chem. 4, 105-111 (1993).
54. Ballou, B., Fisher, G. W., Waggoner, A. S., Farkas, D. L., Reiland, J. M., et al. Tumor Labeling In Vivo Using Cyanine-Conjugated Monoclonal- Antibodies. Cancer Immunol. Immunother. 41, 257-263 (1995).
55. Hirata, T., Kogiso, H., Morimoto, K., Miyamoto, S., Taue, H., et al. Synthesis and Reactivities of 3-indocyanine-green-acyl-1,3-thiazolidine-2-thione (ICG-ATT) as a New Near-infrared Fluorescent-labeling Reagent. Bioorg. Med. Chem. 6, 2179-2184 (1998).
56. Lin, Y. H., Weissleder, R. and Tung, C. H. Novel Near-infrared Cyanine Fluorochromes: Synthesis, Properties, and Bioconjugation. Bioconjugate Chem. 13, 605-610 (2002).
57. Pham, W., Lai, W. F., Weissleder, R. and Tung, C. H. High Efficiency Synthesis of a Bioconjugatable Near-infrared Fluorochrome. Bioconjugate Chem. 14, 1048-1051 (2003).
58. Tarazi, L., George, A., Patonay, G. and Strekowski, L. Spectral Characterization of a Novel Near-infrared Cyanine Dye: A Study of its Complexation with Metal Ions. Talanta 46, 1413-1424 (1998).
59. Gorecki, T., Patonay, G., Strekowski, L., Chin, R. and Salazar, N. Synthesis of Novel Near-infrared Cyanine Dyes for Metal Ion Determination. J. Heterocycl. Chem. 33, 1871-1876 (1996).
60. Ye, Y., Li, W. P., Anderson, C. J., Kao, J., Nikiforovich, G. V., et al. Synthesis and Characterization of a Macrocyclic Near-infrared Optical Scaffold. J. Am. Chem. Soc. 125, 7766-7767 (2003).
61. Pham, W., Weissleder, R. and Tung, C. H. A Practical Approach for the Preparation of Monofunctional Azulenyl Squaraine. Tetrahedron Lett. 44, 3975-3978 (2003).
62. Strekowski, L., Mason, C. J., Lee, H., Gupta, R., Sowell, J., et al. Synthesis of Water-soluble Near-infrared Cyanine Dyes Functionalized With (Succinimido)oxy Carbonyl Group. J. Heterocycl. Chem. 40, 913-916 (2003).
63. Kawasaki, H., Oma, H., Sakaguchi, S., Tominaga, K. and Hirayama, C. Abnormal Binding of Indocyanine Green with Serum Proteins in a Patient with Dealyed ICG Clearance. Clin. Chim. Acta. 47, 39-43 (1973).
64. Kamisaka, K., Listowsky, I., Betheil, J. J., Arias, I. M., Kawasaki, H., et al. Competitive Binding of Bilirubin, Sulfobromophthalein, Indocyanine Green and Other Organic Anions to Human and Bovine Serum Albumin. Biochim. Biophys. Acta 365, 169-180 (1974).
65. Landsman, M., Kwant, J., Mook, G. and Zijlstra, W. Light-absorbing Properties, Stability, and Spectral Stabilization of Indocyanine Green. J. Appl. Physiol. 40, 575-583 (1976).
66. Ott, P., Keiding, S., Bass, L., Landsman, M. L., Kwant, G., et al. Intrinsic Hepatic Clearance of Indocyanine Green in the Pig: Dependence on Plasma Protein Concentration. Eur. J. Clin. Invest. 22, 347-357 (1992).
67. Sutterer, W., Hardin, S., Benson, R., Krovetz, L. and Scheibler, G. Optical Behavior of Indocyanine Green Dye in Blood and in Aqeous Solution. Am. Heart. J. 72, 345-350 (1966).
68. Rajagopalan, R., Uetrecht, P., Bugaj, J. E., Achilefu, S. A. and Dorshow, R. B. Stabilization of the Optical Tracer Agent Indocyanine Green Using Noncovalent Interactions. Photochem. Photobiol. 71, 347-350 (2000).
69. Folli, S., Wagnieres, G., Pelegrin, A., Calmes, J. M., Braichotte, D., et al. Immunophotodiagnosis of Colon Carcinomas in Patients Injected with Fluoresceinated Chimeric Antibodies Against Carcinoembryonic Antigen. Proc. Natl. Acad. Sci. USA 89, 7973-7977 (1992).
70. Polzer, R. J., Coffing, S. L., Marcus, C. B., Park, S. S., Gelboin, H. V., et al. Inhibition of Benzo a Pyrene Metabolism by Insulin, Fitc-Insulin and an Fitc-Insulin-Antibody Conjugate in the Human Hepatoma-Cell Line Hepg2. Chem.-Biol. Interact. 97, 307-318 (1995).
71. Wagnieres, G. A., Studzinski, A. P. and vandenBergh, H. E. Endoscopic Fluorescence Imaging System for Simultaneous Visual Examination and Photodetection of Cancers. Rev. Sci. Instrum. 68, 203-212 (1997).
72. Lazarev, V. V., Roth, R. A., Kazakevich, Y. and Hang, J. Detection of Premalignant Oral Lesions in Hamsters with an Endoscopic Fluorescence Imaging System. Cancer 85, 1421-1429 (1999).
73. Gannot, I., Garashi, A., Gannot, G., Chernomordik, V. and Gandjbakhche, A. In Vivo Quantitative Three-dimensional Localization of Tumor Labeled with Exogenous Specific Fluorescence Markers. Appl. Optics 42, 3073-3080 (2003).
74. Achilefu, S., Jimenez, H. N., Dorshow, R. B., Bugaj, J. E., Webb, E. G., et al. Synthesis, In Vitro Receptor Binding, and In Vivo Evaluation of Fluorescein and Carbocyanine Peptide-based Optical Contrast Agents. J. Med. Chem. 45, 2003-2015 (2002).
75. Bellnier, D. A., Greco, W. R., Loewen, G. M., Nava, H., Oseroff, A. R., et al. Population Pharmacokinetics of the Photodynamic Therapy Agent 2-1-hexyloxyethyl-2-devinyl Pyropheophorbide-a in Cancer Patients. Cancer Res. 63, 1806-1813 (2003).
76. Baas, P., vanGeel, I. P. J., Oppelaar, H., Meyer, M., Beynen, J. H., et al. Enhancement of Photodynamic Therapy by Mitomycin C: A Preclinical and Clinical Study. Br. J. Cancer 73, 945-951 (1996).
77. Kalo, H., Furukawa, K., Sato, M., Okunaka, T., Kusunoki, Y., et al. Phase II Clinical Study of Photodynamic Therapy Using Mono-L-aspartyl Chlorin e6 and Diode Laser for Early Superficial Squamous Cell Carcinoma of the Lung. Lung Cancer 42, 103-111 (2003).
78. Schaffer, M., Ertl-Wagner, B., Schaffer, P. M., Kulka, U., Hofstetter, A., et al. Porphyrins as Radiosensitizing Agents for Solid Neoplasms. Curr. Pharm. Design 9, 2024-2035 (2003).
79. Moghissi, K. and Dixon, K. Photodynamic Therapy (PDT) in Esophageal Cancer: A Surgical View of its Indications Based on 14 Years Experience. Technol. Cancer Res. Treat. 2, 319-326 (2003).
80. Kostron, H., Obwegeser, A. and Jakober, R. Photodynamic Therapy in Neurosurgery: A Review. J. Photochem. Photobiol. B-Biol. 36, 157-168 (1996).
81. Connelly, J. P., Botchway, S. W., Kunz, L., Pattison, D., Parker, A. W., et al. Time-resolved Fluorescence Imaging of Photosensitiser Distributions in Mammalian Cells Using a Picosecond Laser Line-scanning Microscope. J. Photochem. Photobiol. A-Chem. 142, 169-175 (2001).
82. Fischer, F., Dickson, E. F., Pottier, R. H. and Wieland, H. An Affordable, Portable Fluorescence Imaging Device for Skin Lesion Detection Using a Dual Wavelength Approach for Image Contrast Enhancement and Aminolaevulinic Acid-induced Protoporphyrin IX. Part I. Design, Spectral and Spatial Characteristics. Lasers Med. Sci. 16, 199-206 (2001).
83. Licha, K. in Contrast Agents Ii, Vol. 222, pp. 1-29. Springer-Verlag Berlin, Berlin (2002).
84. Zhang, M., Zhang, Z. H., Blessington, D., Li, H., Busch, T. M., et al. Pyropheophorbide 2-deoxyglucosamide: A New Photosensitizer Targeting Glucose Transporters. Bioconjugate Chem. 14, 709-714 (2003).
85. Achilefu, S., Bugaj, J. E., Dorshow, R. B. and Rajagopalan, R. Tumor Targeted Photodiagnostic-phototherapeutic Agents. US Patent Application Publication 20030105300 A1. Published June 5 (2003).
86. Achilefu, S., Rajagopalan, R., Dorshow, R. B. and Bugaj, J. E. Dye-bioconjugates for Simultaneous Optical Diagnostic and Therapeutic Applications. US Patent Application Publication 20030152577 A1. Published August 14 (2003).
87. Doyle, T. C., Burns, S. M. and Contag, C. H. In Vivo Bioluminescence Imaging for Integrated Studies of Infection. Cell Microbiol. 6, 303-317 (2004).
88. Contag, C. H., Jenkins, D., Contag, F. R. and Negrin, R. S. Use of Reporter Genes for Optical Measurements of Neoplastic Disease In Vivo. Neoplasia 2, 41-52 (2000).
89. Tsien, R. Y. The Green Fluorescent Protein. Annu. Rev. Biochem. 67, 509-544 (1998).
90. Yang, M., Baranov, E., Jiang, P., Sun, F. X., Li, X. M., et al. Whole-body Optical Imaging of Green Fluorescent Protein-expressing Tumors and Metastases. Proc. Natl. Acad. Sci. USA 97, 1206-1211 (2000).
91. Ray, P., Pimenta, H., Paulmurugan, R., Berger, F., Phelps, M. E., et al. Noninvasive Quantitative Imaging of Protein-protein Interactions in Living Subjects. Proc. Natl. Acad Sci. USA 99, 3105-3110 (2002).
92. Bhaumik, S. and Gambhir, S. S. Optical Imaging of Renilla Luciferase Reporter Gene Expression in Living Mice. Proc. Natl. Acad. Sci. USA 99, 377-382 (2002).
93. Coralli, C., Cemazar, M., Kanthou, C., Tozer, G. M. and Dachs, G. U. Limitations of the Reporter Green Fluorescent Protein Under Simulated Tumor Conditions. Cancer Res. 61, 4784-4790 (2001).
94. Zaveer, M. S. and Zimmer, M. Structural Analysis of the Immature Form of the GFP Homologue DsRed. Bioorg. Med. Chem. Lett. 13, 3919-3922 (2003).
95. Verkhusha, V. V., Kuznetsova, I. M., Stepanenko, O. V., Zaraisky, A. G., Shavlovsky, M. M., et al. High Stability of Discosoma DsRed as Compared to Aequorea EGFP Biochemistry 42, 7879-7884 (2003).
96. Fradkov, A. F., Verkhusha, V. V., Staroverov, D. B., Bulina, M. E., Yanushevich, Y. G., et al. Far-red Fluorescent Tag for Protein Labelling. Biochem. J. 368, 17-21 (2002).
97. Verkhusha, V. V., Otsuna, H., Awasaki, T., Oda, H., Tsukita, S., et al. An Enhanced Mutant of Red Fluorescent Protein DsRed for Double Labeling and Developmental Timer of Neural Fiber Bundle Formation. J. Biol Chem. 276, 29621-29624 (2001).
98. Jakobs, S., Subramaniam, V., Schonle, A., Jovin, T. M. and Hell, S. W. EGFP and DsRed Expressing Cultures of Escherichia coli Imaged by Confocal, Two-photon and Fluorescence Lifetime Microscopy. FEBS Lett. 479, 131-135 (2000).
99. Wang, Z. F., Shah, J. V., Chen, Z. P., Sun, C. H. and Berns, M. W. Fluorescence Correlation Spectroscopy Investigation of a GFP Mutant-enhanced Cyan Fluorescent Protein and its Tubulin Fusion in Living Cells With Two-photon Excitation. J. Biomed. Opt. 9, 395-403 (2004).
100. Kohl, T., Heinze, K. G., Kuhlemann, R., Koltermann, A. and Schwille, P. A Protease Assay for Two-photon Crosscorrelation and FRET Analysis Based Solely on Fluorescent Proteins. Proc. Natl. Acad. Sci. USA 99, 12161-12166 (2002).
101. Choy, G., O'Connor, S., Diehn, F. E., Costouros, N., Alexander, H. R., et al. Comparison of Noninvasive Fluorescent and Bioluminescent Small Animal Optical Imaging. Biotechniques 35, 1022-1026. 1028-1030 (2003).
102. Troy, T., Jekic-McMullen, D., Sambucetti, L. and Rice, B. Quantitative Comparison of the Sensitivity of Detection of Fluorescent and Bioluminescent Reporters in Animal Models. Molecular Imaging 3, 9-23 (2004).
103. Massoud, T. F. and Gambhir, S. S. Molecular Imaging in Living Subjects: Seeing Fundamental Biological Processes in a New Light. Genes Dev. 17, 545-580 (2003).
104. Goldman, E. R., Balighian, E. D., Mattoussi, H., Kuno, M. K., Mauro, J. M., et al. Avidin: A Natural Bridge for Quantum Dot-antibody Conjugates. J. Am. Chem. Soc. 124, 6378-6382 (2002).
105. Parak, W J., Gerion, D., Pellegrino, T., Zanchet, D., Micheel, C., et al. Biological applications of colloidal nanocrystals. Nanotechnology 14, R15-R27 (2003).
106. Geddes, C. D., Cao, H., Gryczynski, I., Gryczynski, Z., Fang, J. Y., et al. Metal-enhanced Fluorescence (MEF) Due to Silver Colloids on a Planar Surface: Potential Applications of Indocyanine Green to In Vivo Imaging. J. Phys. Chem. A 107, 3443-3449 (2003).
107. Josephson, L., Kircher, M. F., Mahmood, U., Tang, Y. and Weissleder, R. Near-infrared Fluorescent Nanoparticles as Combined MR/Optical Imaging Probes. Bioconjugate Chem. 13, 554-560 (2002).
108. Manning, H. C., Goebel, T., Marx, J. N. and Bornhop, D. J. Facile, Efficient Conjugation of a Trifunctional Lanthanide Chelate to a Pripheral Benzodiazepine Receptor Ligand. Org. Lett. 4, 1075-1078 (2002).
109. Hubbard, D. S., Houlne, M. P., Kiefer, G., Janssen, H. F., Hacker, C., et al. Diagnostic Imaging Using Rare-earth Chelates. Lasers Med. Sci. 13, 14-21 (1998).
110. Hubbard, D. S., Houlne, M. P., Kiefer, G. E., McMillan, K. and Bornhop, D. J. Endoscopic Fluorescence Imaging of Tissue Selective Lanthanide Chelates. Bioimaging 6, 63-70 (1998).
111. Kang, J. S. and Lakowicz, J. R. Fluorescence Resonance Energy Transfer in Calf Thymus DNA From a Long-lifetime Metal-ligand Complex to Nile Blue. J. Biochem. Mol. Biol. 34, 551-558 (2001).
112. Maliwal, B. P., Gryczynski, Z. and Lakowicz, J. R. Long-wavelength Long-lifetime Luminophores. Anal. Chem. 73, 4277-4285 (2001).
113. Barton, J. K., Hoying, J. B. and Sullivan, C. J. Use of Microbubbles as an Optical Coherence Tomography Contrast Agent. Acad. Radiol. 9, S52-S55 (2002).
114. Lee, T. M., Oldenburg, A. L., Sitafalwalla, S., Marks, D. L., Luo, W., et al. Engineered Microsphere Contrast Agents for Optical Coherence Tomography. Opt. Lett. 28, 1546-1548 (2003).
115. Nioka, S., Yung, Y., Shnall, M., Zhao, S., Orel, S., et al. in Oxygen Transport to Tissue Xviii, Vol. 411, pp. 227-232. Plenum Pres Div Plenum Publishing Corp, New York (1997).
116. Reynolds, J. S., Troy, T. L., Mayer, R. H., Thompson, A. B., Waters, D. J., et al. Imaging of Spontaneous Canine Mammary Tumors Using Fluorescent Contrast Agents. Photochem. Photobiol. 70, 87-94 (1999).
117. Bremer, C., Tung, C. H., Bogdanov, A. and Weissleder, R. Imaging of Differential Protease Expression in Breast Cancers for Detection of Aggressive Tumor Phenotypes. Radiology 222, 814-818 (2002).
118. Bremer, C., Tung, C. H. and Weissleder, R. In Vivo Molecular Target Assessment of Matrix Metalloproteinase Inhibition. Nat. Med. 7, 743-748 (2001).
119. Weissleder, R. A Clearer Vision for In Vivo Imaging. Nat. Biotechnol. 19, 316-317 (2001).
120. Weissleder, R., Tung, C. H., Mahmood, U. and Bogdanov, A. In Vivo Imaging of Tumors with Protease-activated Near-infrared Fluorescent Probes. Nat. Biotechnol. 17, 375-378 (1999).
121. Kohl-Bareis, M., Obrig, H., Steinbrink, K., Malak, K., Uludag, K., et al. Noninvasive Monitoring of Cerebral Blood Flow by a Dye Bolus Method: Separation of Brain from Skin And Skull Signals. J. Biomed. Opt. 7, 464-470 (2002).
122. Boehm, T., Hochmuth, A., Malich, A., Reichenbach, J. R., Fleck, M., et al. Contrast-enhanced Near-infrared Laser Mammography with a Prototype Breast Scanner - Feasibility Study with Tissue Phantoms and Preliminary Results of Imaging Experimental Tumors. Invest. Radiol. 36, 573-581 (2001).
123. Gu, Y. Q., Qian, Z. Y., Chen, J. X., Blessington, D., Ramanujam, N., et al. High-resolution Three-dimensional Scanning Optical Image System for Intrinsic and Extrinsic Contrast Agents in Tissue. Rev. Sci. Instrum. 73, 172-178 (2002).
124. Licha, K., Riefke, B., Ntziachristos, V., Becker, A., Chance, B., et al. Hydrophilic Cyanine Dyes as Contrast Agents for Near-infrared Tumor Imaging: Synthesis, Photophysical Properties and Spectroscopic In Vivo Characterization. Photochem. Photobiol. 72, 392-398 (2000).
125. Ntziachristos, V., Bremer, C. and Weissleder, R. Fluorescence Imaging with Near-infrared Light: New Technological Advances that Enable In Vivo Molecular Imaging. Eur. Radiol. 13, 195-208 (2003).
126. Rudin, M. and Weissleder, R. Molecular Imaging in Drug Discovery and Development. Nat. Rev. Drug Discov. 2, 123-131 (2003).
127. Mariani, G., Lasku, A., Balza, E., Gaggero, B., Motta, C., et al. Tumor Targeting Potential of the Monoclonal Antibody BC-1 Against Oncofetal Fibronectin in Nude Mice Bearing Human Tumor Implants. Cancer 80, 2378-2384 (1997).
128. Ballou, B., Fisher, G. W., Hakala, T. R. and Farkas, D. L. Tumor Detection and Visualization Using Cyanine Fluorochrome-labeled Antibodies. Biotechnol. Prog. 13, 649-658 (1997).
129. Ballou, B., Fisher, G. W., Deng, J. S., Hakala, T. R., Srivastava, M., et al. Cyanine Fluorochrome-labeled Antibodies In Vivo: Assessment of Tumor Imaging Using Cy3, Cy5, Cy5.5, and Cy7. Cancer Detect. Prev. 22, 251-257 (1998).
130. Pelegrin, A., Xavier, F., Barbet, J., Bartholeyns, J., Baty, D., et al. Immunotargeting of Tumors: State of the Art and Prospects in 2000. Bull. Cancer 87, 777-791 (2000).
131. Muguruma, N., Ito, S., Bando, T., Taoka, S., Kusaka, Y., et al. Labeled Carcinoembryonic Antigen Antibodies Excitable by Infrared Rays: A Novel Diagnostic Method for Micro Cancers in the Digestive Tract. Intern. Med. 38, 537-542 (1999).
132. Soukos, N. S., Hamblin, M. R., Keel, S., Fabian, R. L., Deutsch, T. F., et al. Epidermal Growth Factor Receptor-targeted Immunophotodiagnosis and Photoimmunotherapy of Oral Precancer in Vivo. Cancer Res. 61, 4490-4496 (2001).
133. Becker, A., Riefke, B., Ebert, B., Sukowski, U., Rinneberg, H., et al. Macromolecular Contrast Agents for Optical Imaging of Tumors: Comparison of Indotricarbocyanine-labeled Human Serum Albumin and Transferrin. Photochem. Photobiol. 72, 234-241 (2000).
134. Ramjiawan, B., Maiti, P., Aftanas, A., Kaplan, H., Fast, D., et al. Noninvasive Localization of Tumors by Immunofluorescence Imaging Using a Single Chain Fv Fragment of a Human Monoclonal Antibody with Broad Cancer Specificity. Cancer 89, 1134-1144 (2000).
135. Ito, S., Muguruma, N., Kusaka, Y., Tadatsu, M., Inayama, K., et al. Detection of Human Gastric Cancer in Resected Specimens using a Novel Infrared Fluorescent Anti-human Carcinoembryonic Antigen Antibody with an Infrared Fluorescence Endoscope In Vitro. Endoscopy 33, 849-853 (2001).
136. Valesky, M., Spang, A. J., Fisher, G. W., Farkas, D. L. and Becker, D. Noninvasive Dynamic Fluorescence Imaging of Human Melanomas Reveals that Targeted Inhibition of bFGF or FGFR-1 in Melanoma Cells Blocks Tumor Growth by Apoptosis. Mol. Med. 8, 103-112 (2002).
137. Bando, T., Muguruma, N., Ito, S., Musashi, Y., Inayama, K., et al. Basic Studies on a Labeled Anti-mucin Antibody Detectable by Infrared-fluorescence Endoscopy. J. Gastroenterol. 37, 260-269 (2002).
138. Ilias, I., Bollas, I., Batsakis, C. and Christakopoulou, I. Tc-99m-labeled Monoclonal Antibody Fragment Imaging in a Patient with Fever of Unknown Origin. Clin. Nucl. Med. 28, 981-983 (2003).
139. Mohamed, I. E., Braun, D. P., Fanning, J., Andrews, S. J., Skeel, R. T., et al. A Phase I/II Pharmacokinetic and Dose Escalation Study of H11 scFv (A Human Monoclonal Antibody Fragment). Breast Cancer Res. Treat. 76, S115-S115 (2002).
140. Ramjiawan, B., Maiti, P., Kaplan, H., Fast, D., Mantsch, H. H., et al. In Vivo Monitoring of the Distribution of a Monoclonal Antibody Fragment. Vib. Spectrosc. 28, 177-188 (2002).
141. Palestro, C. J., Love, C., Marwin, S. E., Tomas, M. B. and Bhargava, K. K. Monoclonal Antibody Fragment Imaging of Osteomyelitis: Enhanced Specificity of Semiquantitative Analysis. J. Nucl. Med. 39, 33P-33P (1998).
142. Juweid, M., Sharkey, R. M., Behr, T. M., Swayne, L. C., Dunn, R., et al. Clinical Evaluation of Tumor Targeting with the Anticarcinoembryonic Antigen Murine Monoclonal Antibody Fragment, MN-14 F(ab)(2). Cancer 78, 157-168 (1996).
143. Morris, J. F., Krishnamurthy, S., Antonovic, R., Duncan, C., Turner, F. E., et al. Tc-99m Monoclonal-Antibody Fragment (Fab) Scintigraphy in the Evaluation of Small-Cell Lung-Cancer - A Preliminary-Report. Nucl. Med. Biol. 18, 613-& (1991).
144. Reubi, J. C., Waser, B., Schaer, J. C. and Laissue, J. A. Somatostatin Receptor sst1-sst5 Expression in Normal and Neoplastic Human Tissues Using Receptor Autoradiography with Subtype-selective Ligands. Eur. J. Nucl. Med. 28, 836-846 (2001).
145. Wangberg, B., Nilsson, O., Johanson, V. V., Kolby, L., Forssell-Aronsson, E., et al. Somatostatin Receptors in the Diagnosis and Therapy of Neuroendocrine Tumor. Oncologist 2, 50-58 (1997).
146. Froidevaux, S. and Eberle, A. N. Somatostatin Analogs and Radiopeptides in Cancer Therapy. Biopolymers 66, 161-183 (2002).
147. de Herder, W. W. and Lamberts, S. W. J. Somatostatin and Somatostatin Analogues: Diagnostic and Therapeutic Uses. Curr. Opin. Oncol. 14, 53-57 (2002).
148. Balon, H. R., Goldsmith, S. J., Siegel, B. A., Silberstein, E. B., Krenning, E. P., et al. Procedure Guideline for Somatostatin Receptor Scintigraphy with In-111-pentetreotide. J. Nucl. Med. 42, 1134-1138 (2001).
149. Lebtahi, R., Le Cloirec, J., Houzard, C., Daou, D., Sobhani, I., et al. Detection of Neuroendocrine Tumors: Tc-99m-P829 Scintigraphy Compared with In-111-pentetreotide Scintigraphy. J. Nucl. Med. 43, 889-895 (2002).
150. Webb, S. M. and Mones, J. Twenty-two Years' Survival of Metastatic Gastrinoma Evidenced Recently by Somatostatin-receptor-specific Scintigraphy. Eur J. Gastroenterol. Hepatol. 14, 333-336 (2002).
151. Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P. M., Konijnenberg, M. W., Srinivasan, A., et al. Lu-177-DOTA(0),Tyr(3) Octreotate: Comparison with In-111- DTPA(0) Octreotide in Patients. Eur. J. Nucl. Med. 28, 1319-1325 (2001).
152. Licha, K., Hessenius, C., Becker, A., Henklein, P., Bauer, M., et al. Synthesis, Characterization, and Biological Properties of Cyanine-labeled Somatostatin Analogues as Receptor-targeted Fluorescent Probes. Bioconjugate Chem. 12, 44-50 (2001).
153. Becker, A., Hessenius, C., Licha, K., Ebert, B., Sukowski, U., et al. Receptor-targeted Optical Imaging of Tumors with Near-infrared Fluorescent Ligands. Nat. Biotechnol. 19, 327-331 (2001).
154. Bugaj, J. E., Achilefu, S., Dorshow, R. B. and Rajagopalan, R. Novel Fluorescent Contrast Agents for Optical Imaging of In Vivo Tumors Based on a Receptor-targeted Dye-peptide Conjugate Platform. J. Biomed. Opt. 6, 122-133 (2001).
155. Zhou, J. H., Chen, J., Mokotoff, M., Zhong, R. K., Shultz, L. D., et al. Bombesin/Gastrin-releasing Peptide Receptor: A Potential Target for Antibody-mediated Therapy of Small Cell Lung Cancer. Clin. Cancer Res. 9, 4953-4960 (2003).
156. Nock, B., Nikotopoulou, A., Chiotellis, E., Loudos, G., Maintas, D., et al. Tc-99m Demobesin 1, A Novel Potent Bombesin Analogue for GRP Receptor-targeted Tumour Imaging. Eur. J. Nucl. Med. Mol. Imaging 30, 247-258 (2003).
157. Zinn, K. R. and Chaudhuri, T. R. The Type 2 Human Somatostatin Receptor as a Platform for Reporter Gene Imaging. Eur. J. Nucl. Med. Mol. Imaging 29, 388-399 (2002).
158. Scopinaro, F., De Vincentis, G., Varvarigou, A. D., Lauremi, C., Iori, F., et al. Tc-99m-bombesin Detects Prostate Cancer and Invasion of Pelvic Lymph Nodes. Eur. J. Nucl. Med. Mol. Imaging 30, 1378-1382 (2003).
159. Okarvi, S. M. and Al-Jammaz, I. Synthesis, Radiolabelling and Biological Characteristics of a Bombesin Peptide Analog as a Tumor Imaging Agent. Anticancer Res. 23, 2745-2750 (2003).
160. Yegen, B. C. Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools. Curr. Pharm. Design 9, 1013-1022 (2003).
161. Hoffman, T. J., Gali, H., Smith, C. J., Sieckman, G. L., Hayes, D. L., et al. Novel Series of In-111-labeled Bombesin Analogs as Potential Radiopharmaceuticals for Specific Targeting of Gastrin-releasing Peptide Receptors Expressed on Human Prostate Cancer Cells. J. Nucl. Med. 44, 823-831 (2003).
162. Kiaris, H., Schally, A. V., Nagy, A., Sun, B., Armatis, P., et al. Targeted Cytotoxic Analogue of Bombesin/Gastrin Releasing Peptide Inhibits the Growth of H-69 Human Small-cell Lung Carcinoma in Nude Mice. Br. J. Cancer 81, 966-971 (1999).
163. Chave, H. S., Gough, A. C., Palmer, K., Preston, S. R. and Primrose, J. N. Bombesin Family Receptor and Ligand Gene Expression in Human Colorectal Cancer and Normal Mucosa. Br. J. Cancer 82, 124-130 (2000).
164. Behr, T. M., Gotthardt, M., Barth, A. and Behe, M. Imaging Tumors with Peptide-based Radioligands. Q. J. Nucl. Med. 45, 189-200 (2001).
165. Hoffman, T. J., Quinn, T. P. and Volkert, W. A. Radiometallated Receptor-avid Peptide Conjugates for Specific In Vivo Targeting of Cancer Cells. Nucl. Med. Biol. 28, 527-539 (2001).
166. Sun, B. D., Halmos, G., Schally, A. V., Wang, X. F. and Martinez, M. Presence of Receptors for Bombesin/Gastrin-releasing Peptide and mRNA for Three Receptor Subtypes in Human Prostate Cancers. Prostate 42, 295-303 (2000).
167. Bajo, A. M., Schally, A. V., Groot, K. and Szepeshazi, K. Bombesin Antagonists Inhibit Proangiogenic Factors in Human Experimental Breast Cancers. Br. J. Cancer 90, 245-252 (2004).
168. Bajo, A. M., Schally, A. V., Krupa, M., Hebert, F., Groot, K., et al. Bombesin Antagonists Inhibit Growth of MDA-MB-435 Estrogen-independent Breast Cancers and Decrease the Expression of the ErbB-2/HER-2 Oncoprotein and c-jun and c-fos Oncogenes. Proc. Natl. Acad. Sci. USA 99, 3836-3841 (2002).
169. Reubi, J. C., Wenger, S., Schmuckli-Maurer, J., Schaer, J. C. and Gugger, M. Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal
170. Karra, S. R., Schibli, R., Gali, H., Katti, K. V., Hoffman, T. J., et al. Tc-99m-labeling and In Vivo Studies of a Bombesin Analogue with a Novel Water-soluble dithiadiphosphine-based Bifunctional Chelating Agent. Bioconjugate Chem. 10, 254-260 (1999).
171. Van de Wiele, C., Dumont, F., Vanden Broecke, R., Oosterlinck, W., Cocquyt, V., et al. Technetium-99m RP527, a GRP Analogue for Visualisation of GRP Receptor-expressing Malignancies: A Feasibility Study. Eur. J. Nucl. Med. 27, 1694-1699 (2000).
172. Markwalder, R. and Reubi, J. C. Gastrin-releasing Peptide Receptors in the Human Prostate: Relation to Neoplastic Transformation. Cancer Res. 59, 1152-1159 (1999).
173. Friry, C., Feliciangeli, S., Richard, F., Kitabgi, P. and Rovere, C. Production of Recombinant Large Proneurotensin Neuromedin N-derived Peptides and Characterization of their Binding and Biological Activity. Biochem. Biophys. Res. Commun. 290, 1161-1168 (2002).
174. Guha, S., Rey, O. and Rozengurt, E. Neurotensin Induces Protein Kinase C-dependent Protein Kinase D Activation and DNA Synthesis in Human Pancreatic Carcinoma Cell Line PANC-I. Gastroenterology 122, A136-A136 (2002).
175. Wang, L., Friess, H., Zhu, Z. W., Graber, H., Zimmermann, A., et al. Neurotensin Receptor-1 mRNA Analysis in Normal Pancreas and Pancreatic Disease. Clin. Cancer Res. 6, 566-571 (2000).
176. Ehlers, R. A., Kim, S. H., Zhang, Y. J., Ethridge, R. T., Murrilo, C., et al. Gut Peptide Receptor Expression in Human Pancreatic Cancers. Ann. Surg. 231, 838-846 (2000).
177. Chavatte, K., Terriere, D., Jeannin, L., Iterbeke, K., Briejer, M., et al. Labelling and Evaluation of New Stabilised Neurotensin (8-13) Analogues for Single Photon Emission Tomography (SPET). J. Label. Compd. Radiopharm. 42, 423-435 (1999).
178. Breeman, W. A. P., de Jong, M., Erion, J. L., Bugaj, J. E., Srinivasan, A., et al. Preclinical Comparison of In-111-labeled DTPA- or DOTA-bombesin Analogs for Receptor-targeted Scintigraphy and Radionuclide Therapy. J. Nucl. Med. 43, 1650-1656 (2002).
179. Garcia-Garayoa, E., Blauenstein, P., Bruehlmeier, M., Blanc, A., Iterbeke, K., et al. Preclinical Evaluation of a New, Stabilized Neurotensin(8-13) Pseudopeptide Radiolabeled with Tc-99m. J. Nucl. Med. 43, 374-383 (2002).
180. Garcia-Garayoa, E., Allemann-Tannahill, L., Blauenstein, P., Willmann, M., Carrel-Remy, N., et al. In Vitro and In Vivo Evaluation of New Radiolabeled Neurotensin(8-13) Analogues with High Affinity for NT1 Receptors. Nucl. Med. Biol. 28, 75-84 (2001).
181. Feng, H. J., Zaidi, J., Cusack, B. and Richelson, E. Synthesis and Biological Studies of Novel Neurotensin(8-13) Mimetics. Bioorg. Med. Chem. 10, 3849-3858 (2002).
182. Leyton, J., Garcia-Marin, L., Jensen, R. T. and Moody, T. W. Neurotensin Causes Tyrosine Phosphorylation of Focal Adhesion Kinase in Lung Cancer Cells. Eur. J. Pharmacol. 442, 179-186 (2002).
183. Lundquist, J. T. and Dix, T. A. Preparation and Receptor Binding Affinities of Cyclic C-terminal Neurotensin (8-13) and (9-13) Analogues. Bioorg. Med. Chem. Lett. 9, 2579-2582 (1999).
184. Lugrin, D., Vecchini, F., Doulut, S., Rodriguez, M., Martinez, J., et al. Reduced Peptide-Bond Pseudopeptide Analogs of Neurotensin - Binding and Biological-Activities, and In Vitro Metabolic Stability. Eur. J. Pharmacol. 205, 191-198 (1991).
185. Gonzalezmuniz, R., Garcialopez, M. T., Gomezmonterrey, I., Herranz, R., Jimeno, M. L., et al. Ketomethylene and (Cyanomethylene) Amino Pseudopeptide Analogs of the C-Terminal Hexapeptide of Neurotensin. J. Med. Chem. 38, 1015-1021 (1995).
186. Achilefu, S., Srinivasan, A., Schmidt, M. A., Jimenez, H. N., Bugaj, J. E., et al. Novel Bioactive and Stable Neurotensin Peptide Analogues Capable of Delivering Radiopharmaceuticals and Molecular Beacons to Tumors. J. Med. Chem. 46, 3403-3411 (2003).
187. Reddy, J. A. and Low, P. S. Folate-mediated Targeting of Therapeutic and Imaging Agents to Cancers. Crit. Rev. Ther. Drug Carr. Syst. 15, 587-627 (1998).
188. Leamon, C. P. and Low, P. S. Folate-mediated Targeting: From Diagnostics to Drug and Gene Delivery. Drug Discov. Today 6, 44-51 (2001).
189. Sudimack, J. and Lee, R. J. Targeted Drug Delivery via the Folate Receptor. Adv. Drug Deliv. Rev. 41, 147-162 (2000).
190. Leamon, C. P. and Low, P. S. Delivery of Macromolecules Into Living Cells - A Method That Exploits Folate Receptor Endocytosis. Proc. Natl. Acad. Sci. USA 88, 5572-5576 (1991).
191. Wiener, E. C., Konda, S., Shadron, A., Brechbiel, M. and Gansow, O. Targeting Dendrimer-chelates to Tumors and Tumor Cells Expressing the High-affinity Folate Receptor. Invest. Radiol. 32, 748-754 (1997).
192. Chen, T., Wong, K. F., Fenske, D. B., Palmer, L. R. and Cullis, P. R. Fluorescent-labeled Poly(ethylene glycol) Lipid Conjugates with Distal Cationic Headgroups. Bioconjugate Chem. 11, 433-437 (2000).
193. Kennedy, M. D., Jallad, K. N., Thompson, D. H., Ben-Amotz, D. and Low, P. S. Optical Imaging of Metastatic Tumors Using a Folate-targeted Fluorescent Probe. J. Biomed. Opt. 8, 636-641 (2003).
194. Moon, W. K., Lin, Y. H., O'Loughlin, T., Tang, Y., Kim, D. E., et al. Enhanced Tumor Detection Using a Folate Receptor-targeted Near-infrared Fluorochrome Conjugate. Bioconjugate Chem. 14, 539-545 (2003).
195. Tung, C. H., Lin, Y. H., Moon, W. K. and Weissleder, R. A Receptor-targeted Near-infrared Fluorescence Probe for In Vivo Tumor Imaging. Chembiochem 3, 784-786 (2002).
196. Nice, E. C., Domagala, T., Fabri, L., Nerriea, M., Walker, F., et al. Rapid Microscale Enzymic Semisynthesis of Epidermal Growth Factor (EGF) Analogues. Growth Factors 20, 71-80 (2002).
197. Ke, S., Wen, X. X., Gurfinkel, M., Charnsangavej, C., Wallace, S., et al. Near-infrared Optical Imaging of Epidermal Growth Factor Receptor in Breast Cancer Xenografts. Cancer Res. 63, 7870-7875 (2003).
198. Whitson, K. B., Beechem, J. M., Beth, A. H. and Staros, J. V. Preparation and Characterization of Alexa Fluor 594-labeled Epidermal Growth Factor for Fluorescence Resonance Energy Transfer Studies: Application to the Epidermal Growth Factor Receptor. Anal Biochem 324, 227-236 (2004).
199. Sokolov, K., Follen, M., Aaron, J., Pavlova, I., Malpica, A., et al. Real-time Vital Optical Imaging of Precancer Using Anti-epidermal Growth Factor Receptor Antibodies Conjugated to Gold Nanoparticles. Cancer Res 63, 1999-2004 (2003).
200. Bhargava, S., Licha, K., Knaute, T., Ebert, B., Becker, A., et al. A Complete Substitutional Analysis of VIP for Better Tumor Imaging Properties. J. Mol. Recognit. 15, 145-153 (2002).
201. Zaheer, A., Lenkinski, R. E., Mahmood, A., Jones, A. G., Cantley, L. C., et al. In Vivo Near-infrared Fluorescence Imaging of Osteoblastic Activity. Nat. Biotechnol. 19, 1148-1154 (2001).
202. Lenkinski, R. E., Ahmed, M., Zaheer, A., Frangioni, J. V. and Goldberg, S. N. Near-infrared Fluorescence Imaging of Microcalcification in an Animal Model of Breast Cancer. Acad. Radial. 10, 1159-1164 (2003).
203. Chen, Y., Zheng, G., Zhang, Z. H., Blessington, D., Zhang, M., et al. Metabolism-enhanced Tumor Localization by Fluorescence Imaging: In Vivo Animal Studies. Opt. Lett. 28, 2070-2072 (2003).
204. Pauwels, E. K. J., Ribeiro, M. J., Stoot, J., McCready, V. R., Bourguignon, M., et al. FDG Accumulation and Tumor Biology. Nucl. Med. Biol. 25, 317-322 (1998).
205. Gambhir, S. S. Molecular Imaging of Cancer with Positron Emission Tomography. Nat. Rev. Cancer 2, 683-693 (2002).
206. Yamada, K., Nakata, M., Horimoto, N., Saito, M., Matsuoka, H., et al. Measurement of Glucose Uptake and Intracellular Calcium Concentration in Single, Living Pancreatic Beta-cells. J. Biol. Chem. 275, 22278-22283 (2000).
207. Ye, Y., Bloch, S. and Achilefu, S. Polyvalent Carbocyanine Molecular Beacons for Molecular Recognitions. J. Am. Chem. Soc., 126, 7740-7741 (2004).